Laboratory use only
This product is supplied only for in-vitro research. It is not for human or veterinary use.
Metabolic Research
Tirzepatide (60mg)
SKU PEP-021-60MGIn Stock
$349.99$529.99AUD
60mg Tirzepatide peptide supplied in Australia — maximum-capacity research vial for the longest protocols. Dual GLP-1/GIP receptor agonist; Phase 3 trials reported up to 22.5% mean body weight reduction over 72 weeks. High-purity lyophilized powder with batch-verified CoA support and fast domestic shipping.
60mg
Pricing and availability are verified by the commerce service when this item is added to your cart.
Batch documentation
Documentation is matched to its applicable batch.
Australian dispatch
Shipping details are confirmed before checkout.
Product information.
Core catalogue and analytical references for this research product.
Visit the CoA library- Presentation
- 60mg
- CAS number
- Not listed
- Reported purity
- 99.810%
- Catalogue ID
- PEP-021-60MG
Research-use guidance.
Important boundaries for responsible laboratory handling.
Verify the applicable batch
Use the SKU and batch identifier on the product label to locate the relevant analytical document.
Follow supplied documentation
Use the labelled storage and handling information associated with the delivered product and batch.
Related products.
More products from metabolic research.
